PCSA News and Press, Processa Pharmaceuticals Inc. From 02/15/24

Processa Pharmaceuticals (NASDAQ: PCSA) , a clinical-stage pharmaceutical company focused on developing the next generation of chemotherapeutic drugs to improve the efficacy and safety for more patients suffering from cancer, will be represented at this month’s Winter Wrap-Up MicroCap Rode...

HANOVER, MD, Feb. 14, 2024 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (Nasdaq: PCSA) (“Processa” or the “Company”), a clinical-stage pharmaceutical company focused on developing the next generation of chemotherapeutic drugs to improve the efficacy and safety ...

2024-02-06 08:48:37 ET More on Processa Pharmaceuticals Processa Pharmaceuticals prices discounted stock and warrants offering to raise $7M Processa stock rallies on NGC-Cap development update Read the full article on Seeking Alpha For further details see: ...

HANOVER, MD, Feb. 06, 2024 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (Nasdaq: PCSA) (“Processa” or the “Company”), a clinical-stage pharmaceutical company focused on developing the next generation of chemotherapeutic drugs to improve the efficacy and safety fo...

Processa Pharmaceuticals (NASDAQ: PCSA) , a clinical-stage pharmaceutical company focused on developing the next generation of chemotherapeutic drugs to improve the efficacy and safety for more patients suffering from cancer, has closed on its previously announced public offering. The offering, w...

HANOVER, MD, Feb. 01, 2024 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (Nasdaq: PCSA) (“Processa” or the “Company”), a clinical-stage pharmaceutical company focused on developing the next generation of chemotherapeutic drugs to improve the efficacy and safety fo...

2024-01-31 10:00:03 ET More on Health Care Select Sector SPDR Healthcare In 2024: Navigating The Biopharma Bull Run XLV Likely Back To Outperforming XLV: Considering The Low-Maintenance Option To Navigate The Healthcare Sector Investors were most bullish on H...

2024-01-30 09:49:29 ET DENVER, Colo., Jan. 30, 2024 ( www.247marketnews.com )- Processa Pharmaceuticals (NASDAQ: PCSA) and Rail Vision (NASDAQ: RVSN) are mentioned in this editorial. Against the odds, you’re finally riding the big wave, but, just like surfing, there may be da...

2024-01-30 08:30:28 ET More on Pre-market losers & stocks. Borr Drilling: Still Undervalued, But The Easy Money Has Already Been Made Borr Drilling: Jackup Market Expected To Remain Strong - Buy Borr Drilling Limited (BORR) Q3 2023 Earnings Call Transcript ...

2024-01-29 10:00:02 ET More on Health Care Select Sector SPDR Healthcare In 2024: Navigating The Biopharma Bull Run XLV Likely Back To Outperforming XLV: Considering The Low-Maintenance Option To Navigate The Healthcare Sector Investors were most bullish on H...